Skip to main content
. 2015 Nov 11;15:898. doi: 10.1186/s12885-015-1898-1

Fig. 1.

Fig. 1

Scatter dot plots of serum irisin levels in patients with invasive breast cancer and controls. Mean values ± standard deviation are also denoted. Serum irisin levels were significantly lower in breast cancer patients compared to controls (2.47 ± 0.57 and 3.24 ± 0.66 μg/ml, respectively, p < 0.001)